Living-related liver transplantation for neonatal-onset propionic acidemia

T Yorifuji1, J Muroi, A Uematsu

  • 1Department of Pediatrics, Kyoto University Hospital, Shogoin Sakyo, Kyoto, Japan.

The Journal of Pediatrics
|October 18, 2000
PubMed

Insights

Living-related liver transplantation successfully treated neonatal-onset propionic acidemia. The procedure corrected hyperammonemia and improved growth and development, despite minimal changes in propionyl CoA metabolites.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Transplantation Surgery

Background:

  • Propionic acidemia is a rare inherited metabolic disorder.
  • Neonatal-onset propionic acidemia presents a severe clinical challenge.
  • Current treatments have limitations in managing metabolic decompensation.

Observation:

  • A child with neonatal-onset propionic acidemia underwent living-related liver transplantation.
  • Post-transplantation monitoring revealed persistent, albeit minimal, circulating propionyl CoA metabolites.

Findings:

  • The liver transplant effectively corrected hyperammonemia.
  • No further episodes of metabolic decompensation occurred post-transplantation.
  • Patients experienced improved natural protein tolerance, corrected anemia, and enhanced growth and cognitive development.

Implications:

  • Living-related liver transplantation is a viable therapeutic option for severe neonatal-onset propionic acidemia.
  • The procedure offers significant long-term benefits in patient outcomes and quality of life.
  • Further research may explore the mechanisms underlying metabolic improvement despite metabolite persistence.

Related Concept Videos